Stourac P - Search Results

1

Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.

Benesová Y, Vasku A, Novotná H, Litzman J, Stourac P, Beránek M, Kadanka Z, Bednarík J. Benesová Y, et al. Among authors: stourac p. Mult Scler. 2009 Mar;15(3):316-22. doi: 10.1177/1352458508099482. Epub 2009 Jan 19. Mult Scler. 2009. PMID: 19153173

2

Paraneoplastic neurological syndromes - patients' cohort profile in the Czech Republic.

Stourac P, Kadanka Z, Palyza V. Stourac P, et al. Acta Neurol Scand. 2001 Aug;104(2):72-7. doi: 10.1034/j.1600-0404.2001.104002072.x. Acta Neurol Scand. 2001. PMID: 11493221

3

Mitoxantrone therapy in rapidly worsening multiple sclerosis.

Benesova Y, Stourac P, Beranek M, Kadanka Z. Benesova Y, et al. Among authors: stourac p. Bratisl Lek Listy. 2005;106(3):141-3. Bratisl Lek Listy. 2005. PMID: 16026151 Clinical Trial.

4

Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.

Benesová Y, Vasků A, Stourac P, Hladíková M, Beránek M, Kadanka Z, Novotná H, Bednarík J. Benesová Y, et al. Among authors: stourac p. J Neuroimmunol. 2008 Dec 15;205(1-2):105-9. doi: 10.1016/j.jneuroim.2008.08.007. Epub 2008 Oct 5. J Neuroimmunol. 2008. PMID: 18835646

5

Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.

Mikulkova Z, Praksova P, Stourac P, Bednarik J, Strajtova L, Pacasova R, Belobradkova J, Dite P, Michalek J. Mikulkova Z, et al. Among authors: stourac p. Cell Immunol. 2010;262(2):75-9. doi: 10.1016/j.cellimm.2010.02.002. Epub 2010 Feb 6. Cell Immunol. 2010. PMID: 20219185

6

Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis.

Mikulkova Z, Praksova P, Stourac P, Bednarik J, Michalek J. Mikulkova Z, et al. Among authors: stourac p. J Neurol Sci. 2011 Jan 15;300(1-2):135-41. doi: 10.1016/j.jns.2010.08.053. J Neurol Sci. 2011. PMID: 20884014 Clinical Trial.

7

Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate.

Hladikova M, Vašků A, Stourač P, Benešová Y, Bednařík J. Hladikova M, et al. Among authors: stourac p. J Neurol Sci. 2011 Apr 15;303(1-2):31-4. doi: 10.1016/j.jns.2011.01.020. Epub 2011 Feb 12. J Neurol Sci. 2011. PMID: 21320707

8

Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.

Praksova P, Stourac P, Bednarik J, Vlckova E, Mikulkova Z, Michalek J. Praksova P, et al. Among authors: stourac p. J Neurol Sci. 2012 Aug 15;319(1-2):18-23. doi: 10.1016/j.jns.2012.05.036. Epub 2012 Jun 5. J Neurol Sci. 2012. PMID: 22676847

9

Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.

Benešová Y, Vašků A, Stourač P, Hladíková M, Fiala A, Bednařík J. Benešová Y, et al. Among authors: stourac p. J Neuroimmunol. 2013 Feb 15;255(1-2):92-6. doi: 10.1016/j.jneuroim.2012.10.014. Epub 2012 Nov 24. J Neuroimmunol. 2013. PMID: 23186557

10

The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.

Kolcava J, Hulova M, Benesova Y, Bednarik J, Stourac P. Kolcava J, et al. Among authors: stourac p. Mult Scler Relat Disord. 2019 May;30:187-191. doi: 10.1016/j.msard.2019.02.019. Epub 2019 Feb 14. Mult Scler Relat Disord. 2019. PMID: 30785075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters